软骨
软骨发生
糖胺聚糖
骨关节炎
细胞生物学
硫酸软骨素
软骨细胞
再生(生物学)
化学
分泌物
细胞外基质
医学
病理
生物化学
生物
解剖
替代医学
作者
Yi-Shan Chen,Wei Sun,Ya Wen,Xiaozhao Wang,Jiachen Li,Shaofang Xie,Rui Li,Yuanzhu Ma,Hongwei Wu,Qiuwen Zhu,Ziheng Chen,Xianzhu Zhang,Youguo Liao,Junxin Lin,Wenyue Li,Yiyang Yan,Dingchao Ying,Qiulin He,Hongxu Meng,Chong Teng
标识
DOI:10.1126/scitranslmed.adl5623
摘要
Osteoarthritis (OA) affects nearly 500 million people worldwide and is characterized by an irreversible loss of glycosaminoglycans (GAGs) at articular cartilage surfaces, which are essential in maintaining cartilage mechanical properties and chondrocyte phenotypes. Despite advances, preserving cartilage GAGs and controlling their turnover in living cells remain challenging. On the basis of the hypothesis that GAGs can interact with cationic molecules, we demonstrated a cost-effective strategy to increase human cartilage GAGs using a cationic polymer hexadimethrine bromide (HDMBr). HDMBr promoted chondrogenesis of mesenchymal stem cells by attracting pericellular GAGs and up-regulating vesicle formation, leading to increased matrix secretion. HDMBr also acted like a molecular assembler to promote the assembly of chondroitin sulfate (CS) into highly concentrated condensates during intracellular trafficking, resulting in more efficient GAG secretion. HDMBr was then evaluated as a potential therapeutic in two animal models. In a rabbit model of large cartilage defects, HDMBr promoted the intrinsic regeneration of GAG-rich hyaline-like cartilage and improved tissue integration. In a rat model of OA, low-dose HDMBr treatment increased cartilage thickness, supported cartilage matrix homeostasis, and supported cell-based therapy, reducing OA damage as compared with other tested clinical treatments. Overall, this study introduces a cost-effective GAG manipulation approach to cartilage repair and joint preservation, offering insights into the mechanisms of cell-material interactions.
科研通智能强力驱动
Strongly Powered by AbleSci AI